Document is current

Any future updates will be listed below

A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA)

Crossref DOI link: https://doi.org/10.1186/s12891-016-0915-0

Published Online: 2016-02-05

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark